Eye
VIDEO: Secondary glaucomas require more careful follow-up
ATLANTA — Secondary glaucomas are related to aqueous outflow and can require closer management, Mitch Ibach, OD, FAAO, said at SECO 2024.
World Optometry Week highlights profession’s commitment to equitable, global eye care
The theme for this year’s World Optometry Week, March 17 to 23, is “Advancing Optometry’s Commitment to Global Eye Care,” the World Council of Optometry announced in a press release.
VIDEO: Vevye improves Schirmer’s scores by 98%
ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.
‘No clear evidence’ that LipiFlow outperforms other treatments for dry eye disease
ATLANTA —There is limited evidence to show that LipiFlow is more effective than commonly used treatments for dry eye disease and meibomian gland dysfunction, according to recently published research.
Alcon introduces ‘water innovations’ contact lens technology portfolio
ATLANTA — Alcon has adopted a comprehensive approach to enabling eye care professionals to speak in patient-friendly terms about the company’s portfolio of contact lenses, Kristen Brotherson said at SECO 2024.
Children from marginalized racial, ethnic groups less likely to receive preventive eye care
Children from historically marginalized racial and ethnic groups and low-income households were less likely to receive vision screening and establish care with a specialist, according to a research letter published in JAMA Ophthalmology.
RetinalGeniX receives patent for device to detect ocular, systemic diseases
RetinalGeniX Technologies has been granted a patent for its System and Method for Visualization of Ocular Anatomy, designed to aid in diagnosis of ocular and systemic diseases, according to a company press release.
Chronic kidney disease associated with late AMD in Asian patients
Chronic kidney disease and compromised kidney function were significantly associated with late age-related macular degeneration, according to a pooled analysis of 10 Asian-based studies.
Macular neovascularization changes persist in AMD, even with long-term anti-VEGF therapy
Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was observed in neovascular age-related macular degeneration, even with frequent anti-VEGF treatment, according to research in PLoS One.
Enrollment complete in phase 3 trial of sozinibercept for wet AMD
Opthea Limited has completed enrollment of its COAST phase 3 clinical trial, a study of sozinibercept in combination with Eylea for wet age-related macular degeneration, the company announced in a press release.